{"id":4012,"date":"2025-02-26T18:35:46","date_gmt":"2025-02-26T18:35:46","guid":{"rendered":"https:\/\/medical-article.com\/?p=4012"},"modified":"2025-02-26T18:35:46","modified_gmt":"2025-02-26T18:35:46","slug":"eikon-raises-350m-for-cancer-drug-pipeline-led-by-melanoma-med-in-pivotal-testing","status":"publish","type":"post","link":"https:\/\/medical-article.com\/?p=4012","title":{"rendered":"Eikon Raises $350M for Cancer Drug Pipeline Led by Melanoma Med in Pivotal Testing"},"content":{"rendered":"<p><a href=\"https:\/\/medcitynews.com\/2025\/02\/eikon-cancer-immunotherapy-melanoma-tlr78-parp-perlmutter\/\"><\/a><\/p>\n<p>Eikon Therapeutics\u2019 lead drug candidate is designed to activate toll-like receptors 7 and 8, sparking an immune response that fights cancer. Beyond this TLR7\/8 agonist, the biotech is also developing PARP inhibitors that could have advantages over cancer drugs currently available from this class.<\/p>\n<p>The post <a href=\"https:\/\/medcitynews.com\/2025\/02\/eikon-cancer-immunotherapy-melanoma-tlr78-parp-perlmutter\/\">Eikon Raises $350M for Cancer Drug Pipeline Led by Melanoma Med in Pivotal Testing<\/a> appeared first on <a href=\"https:\/\/medcitynews.com\/\">MedCity News<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Eikon Therapeutics\u2019 lead drug candidate is designed to activate toll-like receptors 7 and 8, sparking an immune response that fights cancer. Beyond this TLR7\/8 agonist, the biotech is also developing PARP inhibitors that could have advantages over cancer drugs currently available from this class. The post Eikon Raises $350M for Cancer Drug Pipeline Led by&#8230;<\/p>\n","protected":false},"author":0,"featured_media":4013,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-4012","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicine"],"_links":{"self":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/4012"}],"collection":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4012"}],"version-history":[{"count":0,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/4012\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/media\/4013"}],"wp:attachment":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4012"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4012"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4012"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}